About Purple Biotech Purple Biotech Ltd. (NASDAQ/TASE: PPBT) is a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance.

Sarepta, other biotech stocks tumble as FDA appoints new CBER director ...

Pratham EPC Projects Ltd was originally incorporated as Pratham EPC Projects Private Limited as a Private Limited Company vide Certificate of Incorporation dated October 27, 2014 from the ...

31. Subsidiaries/ Associates/ Jvs: Pipeflow Integrity India Private Limited is subsidiary Company of Pratham EPC Projects Limited. The information, pursuant to first proviso to Section 129(3 ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. PALO ALTO, Calif. — At an annual meeting usually focused on the industry ...

Congress should invest at least $15 billion to support biotech research over the next five years and take other steps to bolster manufacturing in the U.S., while barring companies from working ...

For Rituja Suraj Chavan, Managing Director of Valient Biotech Pvt Ltd, starting a company was never just about business—it was about making a difference. The company was founded with a dual ...

The 10 most innovative biotech companies of 2025 are leveraging AI to find new drugs, match patients with the best treatments, and even support biodiversity research. This year’s list of biotech ...

This was supposed to be the year of biotech’s comeback. At least that was the hope of many in the sector who started 2025 pointing to scientific advances and falling interest rates. Some foresaw ...

Please note that Sector and Industry values may differ from other sources, as no adjustments have been made. Pratham EPC Projects Ltd's Revenue of 967.3 M ranks in the 9.5% percentile for the Sector.

Oxford Cannabinoid Technologies is shedding its old skin. Having delisted its stock last year, the biotech is rebranding as Octavian Therapeutics to align with its “growth ambitions and its ...

Dec. 17, 2024 (GLOBE NEWSWIRE) -- Portage Biotech, Inc. (“Portage” or the ... the entire share capital of iOx Therapeutics, Ltd (“iOx”), a wholly owned subsidiary of Portage.